- Home
- IOBT vs PDSB Comparison
IOBT vs PDSB Comparison
Compare IOBT & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- PDSB
- Stock Information
- Founded
- IOBT 2014
- PDSB 2005
- Country
- IOBT Denmark
- PDSB United States
- Employees
- IOBT N/A
- PDSB N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- IOBT Health Care
- PDSB Health Care
- Exchange
- IOBT Nasdaq
- PDSB Nasdaq
- Market Cap
- IOBT 79.7M
- PDSB 72.2M
- IPO Year
- IOBT 2021
- PDSB N/A
- Fundamental
- Price
- IOBT $1.29
- PDSB $1.62
- Analyst Decision
- IOBT Strong Buy
- PDSB Strong Buy
- Analyst Count
- IOBT 3
- PDSB 2
- Target Price
- IOBT $9.33
- PDSB $10.00
- AVG Volume (30 Days)
- IOBT 233.4K
- PDSB 888.3K
- Earning Date
- IOBT 08-12-2025
- PDSB 08-12-2025
- Dividend Yield
- IOBT N/A
- PDSB N/A
- EPS Growth
- IOBT N/A
- PDSB N/A
- EPS
- IOBT N/A
- PDSB N/A
- Revenue
- IOBT N/A
- PDSB N/A
- Revenue This Year
- IOBT N/A
- PDSB N/A
- Revenue Next Year
- IOBT N/A
- PDSB N/A
- P/E Ratio
- IOBT N/A
- PDSB N/A
- Revenue Growth
- IOBT N/A
- PDSB N/A
- 52 Week Low
- IOBT $0.66
- PDSB $0.85
- 52 Week High
- IOBT $1.73
- PDSB $4.42
- Technical
- Relative Strength Index (RSI)
- IOBT 49.63
- PDSB 54.15
- Support Level
- IOBT $1.26
- PDSB $1.53
- Resistance Level
- IOBT $1.57
- PDSB $1.85
- Average True Range (ATR)
- IOBT 0.13
- PDSB 0.14
- MACD
- IOBT -0.04
- PDSB -0.01
- Stochastic Oscillator
- IOBT 19.46
- PDSB 44.86
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.